TOL2581A

Drug TOLMAR, INC.
Total Payments
$119,766
Transactions
24
Doctors
3
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2018 $119,766 24 3

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $119,766 24 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
TOL2581A TOLMAR, INC. $119,766 3

Top Doctors Receiving Payments for TOL2581A

Doctor Specialty Location Total Records
Unknown — San Diego, CA $114,529 15
, MD Pediatric Endocrinology New Rochelle, NY $2,763 3
, MD Pediatric Endocrinology Los Angeles, CA $1,500 3
, MD Pediatric Endocrinology Washington, DC $975.00 3

Manufacturing Companies

Product Information

  • Type Drug
  • Total Payments $119,766
  • Total Doctors 3
  • Transactions 24

About TOL2581A

TOL2581A is a drug associated with $119,766 in payments to 3 healthcare providers, recorded across 24 transactions in the CMS Open Payments database. The primary manufacturer is TOLMAR, INC..

Payment data is available from 2018 to 2018. In 2018, $119,766 was paid across 24 transactions to 3 doctors.

The most common payment nature for TOL2581A is "Unspecified" ($119,766, 100.0% of total).

TOL2581A is associated with 1 research study, including "TOL2581A" ($119,766).